| Financial Year |
March 31 2023 |
| Monetary Funds |
8,123,544.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
113,953,931.81 |
| Advances to Suppliers |
414,934.61 |
| Other Receivables |
120,034,918.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
106,367,306.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,016,742.26 |
| Total Current Assets |
351,911,378.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
273,561,887.34 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,311,859.10 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
168,330.23 |
| Deferred Income Tax Assets |
2,627,500.98 |
| Other Non-Current Assets |
10,865,914.00 |
| Sub-Total of Non-Current Assets |
353,696,128.12 |
| Total Assets |
705,607,506.82 |
| Short-Term Loans |
28,733,694.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
67,029,212.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,636,701.90 |
| Taxes Payable |
4,338,061.07 |
| Interest Payable |
3,334,790.34 |
| Dividend Payable |
-- |
| Other payables |
42,012,434.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,098,613.69 |
| Other Current Liabilities |
92,193.14 |
| Sub-Total of Current Liabilities |
159,547,554.73 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,284,259.16 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,613,246.16 |
| Total Liabilities |
171,160,800.89 |
| Paid-In Capital(Or Share Stock) |
470,800,000.00 |
| Capital Surplus |
54,683,587.47 |
| Surplus Reserve |
47,934,695.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-20,651,567.40 |
| Minority Stockholder's Interest |
-17,573,716.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
552,020,422.65 |
| Owner's Equity（Stockholder's Equity） |
534,446,705.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
705,607,506.82 |
